Product Information
IYUZEH 0.005% EYE DROP is a brand product labeled by Thea Pharma Inc., priced at $10.1227 per EA under NDC 82584000330. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on Dec 13, 2022.
Strength
50 ug/mL
Manufacturer
Thea Pharma Inc.NDC
82584000330
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LATANOPROSTApproval Type
New Drug (NDA)
FDA Application
NDA216472FDA Approved
12/13/2022
On Market Since
7/14/2023
Price Statistics
The NADAC for IYUZEH 0.005% EYE DROP has been published 137 times since Feb 21, 2024, and over the history we have for it it has risen 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1227 per EA |
|---|---|
| All-time high | $10.1535 (Mar 12, 2025) |
| All-time low | $9.5007 (Feb 21, 2024) |
| 52-week high | $10.1254 |
| 52-week low | $10.1187 |
| Median price | $10.1227 |
| Average price | $9.9802 |
| Largest weekly change | +6.0% (Nov 6, 2024) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Latanoprost Ophthalmic Solution 0.005% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Thea Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Latanoprost Ophthalmic Solution 0.005% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IYUZEH 0.005% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for IYUZEH 0.005% EYE DROP, manufactured by Thea Pharma Inc., is $10.1227 per EA (NDC 82584000330), effective Sep 30, 2026.
How has the price of IYUZEH 0.005% EYE DROP changed over time?
Over the history we have for it, the NADAC for IYUZEH 0.005% EYE DROP has risen 6.5%. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for IYUZEH 0.005% EYE DROP?
Since Feb 21, 2024, the NADAC for IYUZEH 0.005% EYE DROP has ranged from a low of $9.5007 (Feb 21, 2024) to a high of $10.1535 (Mar 12, 2025), with a median of $10.1227 per EA.
Are there cheaper alternatives to IYUZEH 0.005% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of IYUZEH 0.005% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures IYUZEH 0.005% EYE DROP?
IYUZEH 0.005% EYE DROP (NDC 82584000330) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.